Skip to main content
. 2018 Jul 27;62(8):e00248-18. doi: 10.1128/AAC.00248-18

FIG 4.

FIG 4

Effect of efflux pump blocker on clofazimine efficacy. The bacterial burden in HFS-Mkn treated with the human-equivalent clofazimine dose of 100 mg/day in combination with reserpine was 0.56-log10 CFU/ml lower than that achieved with clofazimine alone and 0.95-log10 CFU/ml lower than that achieved in the nontreated HFS-Mkn on day 21.